Rekenbi intravenous infusion 200 mg (lecanemab), manufactured by Eisai, is approved in Japan for slowing the progression of mild cognitive impairment and mild dementia due to Alzheimer’s disease. The YJ code is 1190408A1025 and the standard is 200mg 2mL 1 bottle.
Rekenbi intravenous infusion 200 mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).